tiprankstipranks
Ocean Biomedical Faces Nasdaq Compliance Challenges
PremiumCompany AnnouncementsOcean Biomedical Faces Nasdaq Compliance Challenges
3M ago
Ocean Biomedical receives noncompliance notification from Nasdaq
Premium
The Fly
Ocean Biomedical receives noncompliance notification from Nasdaq
3M ago
Ocean Biomedical congratulates joint venture partner Virion Therapeutics
Premium
The Fly
Ocean Biomedical congratulates joint venture partner Virion Therapeutics
6M ago
Ocean Biomedical receives Nasdaq notice regarding late filing
PremiumThe FlyOcean Biomedical receives Nasdaq notice regarding late filing
7M ago
Ocean Biomedical congratulates Virion on Phase 1b data for VRON-0200
Premium
The Fly
Ocean Biomedical congratulates Virion on Phase 1b data for VRON-0200
8M ago
Ocean Biomedical Inc options imply 21.0% move in share price post-earnings
Premium
The Fly
Ocean Biomedical Inc options imply 21.0% move in share price post-earnings
8M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
9M ago
Ocean Biomedical Inc options imply 31.8% move in share price post-earnings
Premium
The Fly
Ocean Biomedical Inc options imply 31.8% move in share price post-earnings
9M ago
Ocean Biomedical announces Virion to present study of VRON-0200
Premium
The Fly
Ocean Biomedical announces Virion to present study of VRON-0200
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100